Researchers integrated scRNA-seq and bulk sequencing data to identify biomarkers that affect pancreatic ductal adenocarcinoma survival and identified MYADM as one of the differentially expressed genes in ductal cells between normal and tumor tissues 21. Here, MYADM is linked to pancreatic ductal adenocarcinoma.